From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation
Group
One copy
Two copies
χ2 (p)
OR (95% CI)
Model 1
Model 2
Cases
15 (5.1)
282 (94.9)
5.19 (0.02)
3.40 (1.12–10.39)
4.49 (1.3–15.52)
Controls
4 (1.5)
256 (98.5)